Patel Sandeep, Rajnish Rajesh Kumar, Baburaj Vishnu, Kumar Prasoon, Sharma Siddhartha, Kumar Vishal
Department of Orthopaedics, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Department of Orthopaedics, All India Institute of Medical Sciences, Rajasthan 342005 Jodhpur, India.
Indian J Orthop. 2022 Sep 9;56(11):1847-1857. doi: 10.1007/s43465-022-00737-x. eCollection 2022 Nov.
The role of subchondral bone as a key mediator in pathogenesis of osteoarthritis (OA) is emerging and various injectable modalities are being tried to address the subchondral pathology. Intraosseous (IO) infiltrations of PRP is biological way of addressing the pathology. This review aimed to explore the role of IO PRP in OA knees.
A systematic literature search was conducted on the electronic databases of PubMed, Embase, Scopus, Web of Science and Ovid for relevant articles on IO PRP with a predefined search strategy. Data from eligible studies were extracted and was analyzed.
There were only five studies on the study topic which included 112 patients (112 knees) who received IO PRP injection. IO PRP was associated with significant improvements in VAS, KOOS and WOMAC scores. The most commonly reported complication was pain at injection site. Meta-analysis revealed that combined intraarticular (IA) and IO PRP were associated with significantly better WOMAC scores, compared to only IA PRP. However, VAS and KOOS scores were equivocal.
IO PRP infiltration for OA knees is safe and effective and results in improved patient-reported outcome scores based on the current limited literature. However, its added advantage over only IA PRP is not well established and clear due to limited available published data.
作为骨关节炎(OA)发病机制中关键介质的软骨下骨作用日益凸显,人们尝试了多种注射方式来处理软骨下病理改变。富血小板血浆(PRP)的骨内(IO)注射是一种针对该病理改变的生物学方法。本综述旨在探讨IO PRP在OA膝关节中的作用。
采用预定义的搜索策略,在PubMed、Embase、Scopus、Web of Science和Ovid等电子数据库中对有关IO PRP的相关文章进行系统的文献检索。提取符合条件的研究数据并进行分析。
关于该研究主题仅有五项研究,共纳入112例接受IO PRP注射的患者(112个膝关节)。IO PRP与视觉模拟评分法(VAS)、膝关节损伤和骨关节炎疗效评分(KOOS)以及西安大略和麦克马斯特大学骨关节炎指数(WOMAC)评分的显著改善相关。最常报告的并发症是注射部位疼痛。荟萃分析显示,与单纯关节内(IA)注射PRP相比,联合IA和IO注射PRP与显著更好的WOMAC评分相关。然而,VAS和KOOS评分并不明确。
基于目前有限的文献,IO PRP注射治疗OA膝关节是安全有效的,且能改善患者报告的结局评分。然而,由于公开的可用数据有限,其相对于单纯IA PRP的额外优势尚未明确确立。